FARXIGA is not for use to improve blood sugar (glucose) control in people with type 2 diabetes who have moderate to severe kidney problems, because it may not work.

Dec 12, 2025 · Farxiga (dapagliflozin) is an oral diabetes medication that can also treat chronic kidney disease (CKD) in adults. It can help prevent kidney function from worsening and lower …

FARXIGA is not recommended for the treatment of chronic kidney disease in patients with polycystic kidney disease or patients requiring or with a recent history of immunosuppressive …

Sep 24, 2020 · We designed the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) trial to assess the long-term efficacy and safety of the SGLT2 …

May 14, 2020 · In April 2021, the US Food and Drug Administration (FDA) approved Farxiga to reduce the risk of kidney function decline, kidney failure, cardiovascular death and …

Farxiga (dapagliflozin), an FDA-approved medication for CKD, offers a viable solution for patients seeking improvements in kidney function and renal protection. Farxiga works by inhibiting …

In DAPA-CKD Phase III trial, FARXIGA demonstrated unprecedented reduction in the risk of the composite of worsening of renal function, end stage kidney disease and cardiovascular or …

May 16, 2024 · Farxiga is approved for use in reducing the risk of chronic kidney disease progression, a disease with shocking incidence, particularly among those with diabetes. By …

Dapagliflozin, sold under the brand names Farxiga (US) and Forxiga (EU) among others, is a medication used to treat type 2 diabetes. [6][7][10] It is also used to treat adults with heart …

Learn the facts about FARXIGA® (dapagliflozin) for chronic kidney disease (CKD). See how it works, benefits, and key information to help you have informed treatment.